A pre-planned feasibility analysis (based on run-in data from 2253 participants across all tumour cohorts), suggested that aspirin is well-tolerated after radical therapy, with a low burden of toxicit ...
News
Posting CRFs to the correct address
A reminder to all UK and ROI sites: Please ensure you are posting CRFs to the correct address. MRC CTU has been based at 2nd Floor, 90 High Holborn, London, WC1V 6LJ since October 2017. Post going ...
Gastro-oesophageal Screening Log
2018 was our best year yet for recruitment to the gastro-oesophageal cohort! Many thanks to all of you who have contributed to this success with your hard work.As we move forward into 2019 we would li ...
New study looking at risks and benefits of daily aspirin
A number of news outlets recently reported on a new study which has looked at the benefits and risks of taking daily aspirin for individuals without a history of heart disease. The study pooled data ...
News and Resources